IN8bio, Inc.

NASDAQ:INAB

0.2301 (USD) • At close October 17, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q22020 Q12019 Q42019 Q3
Assets:
Current Assets:
Cash & Cash Equivalents 10.21713.01521.28212.85416.99310.8618.18227.64725.74232.10737.02140.67511.99915.05217.9943.18-0.610.610.61
Short Term Investments 00000000000000001.2200
Cash and Short Term Investments 10.21713.01521.28212.85416.99310.8618.18227.64725.74232.10737.02140.67511.99915.05217.9943.180.610.610.61
Net Receivables 0000000000000000000
Inventory 0000000000000000000
Other Current Assets 2.4650.5393.3430.2620.2773.5420.2322.0071.2571.1671.9590.0350.1680.320.150.14500.0480.153
Total Current Assets 12.68215.75524.62516.54919.46514.40222.23429.65426.99933.27438.9843.87712.16715.37218.1443.3250.610.7630.763
Non-Current Assets:
Property, Plant & Equipment, Net 9.2359.2188.5739.159.7459.76810.1728.123.4912.8552.8342.8481.8941.7760.1860.2300.2740.274
Goodwill 0000000000000000000
Intangible Assets 0000000.1260.12600000000000
Goodwill and Intangible Assets 0000000.1260.12600000000000
Long Term Investments 0.2590.2560.2560.2540.2530.2530.2520.2520.2520.2510.25100000000
Tax Assets 000000-0.252-0.25200000000000
Other Non-Current Assets 0.320.320.2550.2550.2550.2550.5070.4830.2460.1580.1580.4093.5033.2752.580.092-0.610.0930.093
Total Non-Current Assets 9.8149.7949.0849.65910.25310.27610.8058.7293.9893.2643.2433.2575.3975.0512.7660.322-0.610.3670.367
Total Assets 22.49625.54933.70926.20829.71824.67833.03938.38330.98836.53842.22347.13417.56420.42320.913.64701.131.13
Liabilities & Equity:
Current Liabilities:
Account Payables 1.4441.4130.9240.7480.5850.872.0911.1080.8870.5530.3950.6920.4620.660.620.56100.560.56
Short Term Debt 1.7821.5361.5141.4981.5221.3861.3890.9150.560.6310.6260.6280.8260.770.1740.058000
Tax Payables 0000000000000000000
Deferred Revenue 0000000000000000000
Other Current Liabilities 1.5330.8952.9552.441.6741.4922.3422.8771.5250.8841.2350.841.4851.6321.7781.24800.0870.087
Total Current Liabilities 4.7593.8445.3934.6863.7813.7485.8224.92.9722.0682.2562.162.7733.0622.5721.86700.6470.647
Non-Current Liabilities:
Long Term Debt 4.1164.1793.3793.7644.1384.1424.4853.9191.4481.6351.7841.9361.131.04200.116000
Deferred Revenue Non-Current 0000000000000000000
Deferred Tax Liabilities Non-Current 0000000000000000000
Other Non-Current Liabilities -0000000000000000.829000
Total Non-Current Liabilities 4.1164.1793.3793.7644.1384.1424.4853.9191.4481.6351.7841.9361.131.0420.0170.94500.8290
Total Liabilities 8.8758.0238.7728.457.9197.8910.3078.8194.423.7034.044.0963.9034.1042.5892.81201.4760.647
Equity:
Preferred Stock 0000000000047.13434.934.934.914.3579.7258.8969.725
Common Stock 0.0050.0040.0040.0040.0040.0030.0030.0030.0020.0020.0020.0030.0010.0010.0010.00100.0010.001
Retained Earnings -108.41-99.781-91.219-83.621-76.452-68.737-61.212-53.414-46.015-38.836-32.691-26.842-23.451-20.401-18.038-14.0460-9.481-9.481
Accumulated Other Comprehensive Income/Loss 000-00-000000-47.1340000-9.24200
Other Total Stockholders Equity 122.026117.303116.152101.37598.24785.52283.94182.97572.58171.66970.87222.7432.2111.8191.4580.52300.2380.238
Total Shareholders Equity 13.62117.52624.93717.75821.79916.78822.73229.56426.56832.83538.18343.03813.66116.31918.3210.8350.483-0.3460.483
Total Equity 13.62117.52624.93717.75821.79916.78822.73229.56426.56832.83538.18343.03813.66116.31918.3210.8350.483-0.3460.483
Total Liabilities & Shareholders Equity 22.49625.54933.70926.20829.71824.67833.03938.38330.98836.53842.22347.13417.56420.42320.913.6470.4831.131.13